Performance comparison of germline variant calling tools in sporadic disease cohorts.

Researchers compared two computer programs used to analyze genetic test results in people with epilepsy and autism. They found that each program had different strengths - one was better at finding common genetic changes, while the other was better at finding rare ones that might cause disease. This suggests doctors and researchers should choose their analysis tools carefully depending on what they're looking for.

This study compared two genetic testing tools (DeepVariant and GATK HaplotypeCaller) for detecting genetic variants in Chinese individuals with sporadic epilepsy and autism spectrum disorder. DeepVariant showed better overall accuracy for finding single nucleotide variants, while GATK was superior at identifying rare genetic variants that are often crucial for understanding rare diseases. The research highlights that different genetic analysis tools have distinct strengths and weaknesses, suggesting that the choice of tool should be tailored to specific clinical needs. This work provides practical guidance for optimizing genetic testing pipelines in neurodevelopmental disorders and has implications for precision medicine approaches.

Results suggest genetic testing laboratories should consider using different variant calling tools depending on clinical context. For rare disease diagnosis, GATK may be preferred for rare variant detection, while DeepVariant may offer better overall accuracy. Tailored bioinformatics approaches could improve diagnostic yield in neurodevelopmental disorders.

Sample size not reported. Study limited to Chinese populations, which may affect generalizability to other ethnicities. Comparison focused on only two variant calling tools. Clinical validation of identified variants not described in the abstract.

Accurate variant calling is essential for next-generation sequencing (NGS)-based diagnosis of rare diseases, yet most benchmarking studies have focused on standard cell lines or trio-based samples, with limited relevance to sporadic cases. Here, we systematically compared the performance of DeepVariant and GATK HaplotypeCaller in two Chinese cohorts of patients with sporadic epilepsy (EP) and autism spectrum disorder (ASD). DeepVariant exhibited higher precision and sensitivity in detecting single nucleotide variants (SNVs), while GATK showed a distinct advantage in identifying rare variants, which are often key to understanding the genetic basis of rare diseases. Comparative analyses based on disease-related gene panels further highlighted differences in the identification of potentially deleterious variants.

These findings reveal important trade-offs between variant callers and emphasize the need to tailor variant-calling strategies to specific research and clinical contexts. Our study provides practical vision for optimizing germline variant detection pipelines in sporadic neurodevelopmental disorders, offering broader insights for precision medicine applications.